TORONTO, ON, Canada – April 11 (SEND2PRESS NEWSWIRE) — When it comes to health related therapies, compliance is an issue for millions of Americans. Whether it’s forgetting to take a daily pill for birth control or cholesterol, testing blood glucose levels for diabetes, or heart or HIV medications we all have the tendency to forget. It has been well documented that America’s population is aging. Providing a solution to our aging and more active patient population, MemoText(R) from Enterprising Vision Inc. now offers reminder services to any telephone, landline or cellular phone in order to accommodate, and integrate into, the lifestyle of the patient.
Depending on the needs of the patient, reminder notifications are delivered via automated outbound voice and/or SMS text message. Conveniently, enrollment can be done online or offline from any phone line or Internet connection. And with MemoText’s unique “Follow Me” technology patients can tailor a messaging/reminder service that fits within their own already established life schedule.
Using this technology, MemoText(R) offers a comprehensive, tailored, and cost effective patient adherence solution for health stakeholder organizations, caregivers and direct-to-patients.
Studies show that compliance for patients with chronic conditions is extremely poor. Even after a short period of time, the dropout rate for treatments like anti-hypertensive and cholesterol-lowering drugs is as high as 50 percent. With 70% of all prescriptions never even consumed and 20% of all new drug prescriptions never filled for even the first time it is no surprise that hospitalizations, insurance premiums and healthcare costs are all trending up. 
The cost of non-compliance to medication regiments represents almost two percent of US hospitalization costs and accounts for approximately six percent of all hospitalizations. The potential savings made available by improved adherence are in the magnitude of $80bn in the US alone. 
“We are proud to introduce a low-cost, easy to use solution for people who require assistance with medication compliance,” says Danielle Keystone-Adler, VP Business Development. “At MemoText(R), we are committed to improving adherence across the healthcare spectrum and we believe our new voice offering will help address this need.”
Patients can sign up directly by dialing 1.877.Memo.Txt (1.877.636.6898) or logging on at www.memotext.com. MemoText(R) also provides both large-scale and small-business patient adherence solutions to stakeholder organizations such as pharmaceutical companies, third party insurers, HMOs, governments, and pharmacies. Demo accounts available for journalists.
MemoText(R) is a service brought to you by Enterprising Vision Inc. and Halex Technology Consulting Inc. For more information please visit www.enterprisingvision.com and www.halex.com.
MemoText(R) is a proud supporter of the Canadian Diabetes Association.
1: Roner, Lisa. Briefing: “Understanding patient non-compliance” (6/28/2005), eyeforpharma.
2: m-Healthcare Initiatives for Improving Outpatient Adherence: Opportunities and Barriers, Cocosila, M. and N. Archer, McMaster University eBusiness Research Centre (MeRc), June 2005.
3: Assessing the damage: Estimating the Economic Burden of Prescription Drug Non-Adherence in Canada, Iskedjian, M. Canadian Healthcare Manager.]